Titlebook: Chemosensitivity; Volume I: In Vitro A Rosalyn D. Blumenthal Book 2005 Humana Press 2005 cell.cell culture.cell death.chemotherapy.imaging.

摻假

Chemosensitivity Testing Using Microplate Adenosine Triphosphate-Based Luminescence Measurements, technique; low technical failure rates; and a high methodological efficacy requiring only 1 × 10. tumor cells to test four to six different drugs or combinations. In ovarian and breast carcinomas, the predictive accuracy is <90%, with a positive predictive value of 85-90‰ and a negative predictive

作繭自縛

使迷醉

archaeology

Image Analysis Using the Fluorochromasia Assay to Quantify Tumor Drug Sensitivity,10, 30, or 100 MNC-190. The potential benefit of this technique is the ability to predict the response of tumors to chemotherapeutic agents as a laboratory tool for preclinical drug evaluation and clinically prior to the commencement of therapy.

四溢

郊外

Immunohistochemistry of p53, Bcl-2, and Ki-67 as Predictors of Chemosensitivity,ponse assay method using four drugs: mitomycin C, 5-fluorouracil, doxorubicin hydrochloride (ADM), and cisplatin (CDDP). Immunohistochemical studies for p53 were found to be useful for predicting chemosensitivity.

大方一點(diǎn)

說不出

Adaptive Optics in Multiphoton Microscopyrvival curves have been generated for many established cell lines growing in culture. One can use cell lines from various origins including humans and rodents; these cells can be neoplastic or normal. Because survival curves have wide application in evaluating the reproductive integrity of different

FLORA

Fu-Jen Kao,Gerd Keiser,Ankur Gogoiassays such as MTT or clonogenic assay. The SRB assay possesses a colorimetric end point and is nondestructive and indefinitely stable. These practical advances make the SRB assay an appropriate and sensitive assay to measure drug-induced cytotoxicity even at large-scale application.

jeopardize

K. F. Wang,Zhenzhou Ji,Mingzeng Hu technique; low technical failure rates; and a high methodological efficacy requiring only 1 × 10. tumor cells to test four to six different drugs or combinations. In ovarian and breast carcinomas, the predictive accuracy is <90%, with a positive predictive value of 85-90‰ and a negative predictive